ArticlePloS one2026
Estimated true prevalence and associated risk factors of bovine paratuberculosis antibodies in dairy herds in Bangladesh.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine paratuberculosis (PTB), caused by Mycobacterium avium subsp. paratuberculosis (MAP), is a chronic infection that undermines cattle productivity and farm profitability. In Bangladesh, no previous studies have estimated PTB prevalence or identified associated risk factors. This cross-sectional study (January 2023 to December 2024) was conducted across 14 districts and 138 dairy farms to estimate true MAP antibody prevalence and identify factors associated antibody detection. Bulk milk samples from all herds (n = 138) and 880 individual milk samples from ELISA-positive herds were tested using a commercial indirect ELISA. True herd- and cow-level antibody prevalence was estimated using Bayesian latent class models. Risk factors were identified using multivariable logistic regression (herd-level) and mixed-effects logistic regression (cow-level). The apparent antibody prevalence was 7.2% at the herd-level and 12.2% at the cow-level, with herd-level prevalence ranging from 0.9% to 37%. After adjusting for test sensitivity and specificity, true antibody prevalence estimates decreased to 4.9% (herd level) and 9.4% (cow level). Herds with more than two retained placenta cases had significantly higher odds of MAP antibody detection (odds ratio [OR] = 9.42) than herds with two or fewer such events. At the cow level, older age (>7.9 years) was associated with higher odds of antibody positivity compared with cows ≤4 years. Cows with anestrus (OR = 3.89) or repeat breeding (OR = 2.63) had significantly higher odds of MAP antibody detection compared with cows without these disorders. Milk antibody levels showed a negative association with milk yield, with each unit increase in the sample-to-positive ratio corresponding to a 0.018 L/day reduction. These findings indicate that apparent antibody prevalence substantially overestimates PTB exposure in the study areas. The associations with retained placenta, anestrus, and repeat breeding suggest potential reproductive impacts that warrant further investigation. Given the purposive sampling strategy and reliance on milk ELISA, the results should be interpreted within the context of the study population. Enhancing diagnostic capacity and integrating PTB considerations into reproductive herd management may help reduce productivity losses, while larger, probability-based studies are needed to assess the national burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.